Results 181 to 190 of about 1,514,926 (296)

Allocative efficiency of opioid overdose prevention strategies for people incarcerated in New Jersey. [PDF]

Harm Reduct J
Scheidell JD, Frechette JM, Townsend TN, Zhou Q, Manandhar-Sasaki P, Kaldany H, Connelly KL, Cortes AP, Su JI, Charles DL, Braithwaite RS.   +10 more
europepmc   +1 more source

The impact of harm reduction interventions on injection‐related bacterial infections among people who inject drugs: A systematic review

Addiction, EarlyView.
Abstract Background and aims Injection‐related bacterial infections represent a major but under‐recognised health issue among people who inject drugs (PWID). Harm reduction interventions (HRIs) like needle and syringe programmes (NSP) and opioid agonist treatment (OAT) could mitigate their burden.
Anthony Cousien, Lobna Tijani, Nadia Hachicha, Manon Godart, Mathieu Castry, Karen Champenois, Perrine Roux, Sylvie Deuffic‐Burban   +7 more
wiley   +1 more source

A Narrative Review on Toxidromes in the Psychiatric Population: Implications for Overdose Prevention. [PDF]

J Clin Med
Dutta S, Buciuc AG, Barry P, Padilla V.
europepmc   +1 more source

Prescribed pharmaceutical alternatives initiative coinciding with reductions in unregulated street opioid use among young people who use drugs: An interrupted time series analysis

Addiction, EarlyView.
Abstract Background and aims In British Columbia, Canada, an initiative was implemented in 2020 to reduce overdose mortality by prescribing pharmaceutical opioids (primarily hydromorphone) as a substitute for the toxic unregulated drug supply. This study estimated changes in the level and trend of unregulated opioid use and non‐prescribed hydromorphone
Erica McAdam, Mohammad Karamouzian, Michael John Milloy, Carmen Verdicchio, Eric C. Sayre, Kanna Hayashi, Thomas Kerr, Kora DeBeck   +7 more
wiley   +1 more source

"Because we're the experts": centering the expertise of people who use drugs to identify and propose solutions for overdose prevention. [PDF]

Harm Reduct J
Bailey EJ, Becker M, Morrow J, Schaefer R, Angeles S, Kemp P, Crews Z, Mijal K, Striebel J, Conway CJ, Claypool E, Seal DW, Salisbury-Afshar EM, Westergaard RP, Gicquelais RE.   +14 more
europepmc   +1 more source

County by county estimation of possible deaths averted, infections averted, and cost savings of overdose prevention centers in the United States from July 2019-June 2025. [PDF]

Int J Drug Policy
Bailey K, Palli R, Sportiello M.
europepmc   +1 more source

Prescribed alternative stimulants among people who use unregulated stimulants: Examining the association between maximum dose reached and medication discontinuation in the first 3 years of implementation in British Columbia, Canada

Addiction, EarlyView.
Abstract Background and aims In 2020, British Columbia (BC), Canada, introduced ‘Prescribed Alternatives’ (PA) as an approach to offering regulated substances to people accessing the unregulated supply. This study aimed to estimate and compare prescribing characteristics of dextroamphetamine and methylphenidate stimulant PAs in BC, to estimate ...
Bin Zhao, Kevin Hu, Roshni Desai, Shania Au, Kali‐olt Sedgemore, Vitor Tardelli, Addie Carter, Paxton Bach, Christian Schutz, Amanda Slaunwhite, Alexis Crabtree, Heather Palis   +11 more
wiley   +1 more source

Overdose Prevention Centers and Neighborhood Commercial Activity in New York City.

JAMA Netw Open
Allen B, Basaraba C, Chambers LC, Behrends CN, Marshall BDL, Cerdá M.   +5 more
europepmc   +1 more source

Naloxone Availability, Testing Drugs for Potency, and Solitary Use: Unpacking the Determinants of Overdose Prevention Behaviors. [PDF]

Subst Use Misuse
Latkin CA, Dayton L, Bonneau H, Davey-Rothwell MA, Santos-Silva L, Yi G, Falade-Nwulia O.   +6 more
europepmc   +1 more source

Clinicians' and people who use drugs' perspectives on artificial intelligence in addiction medicine

Addiction, EarlyView.
Abstract Background and aims Artificial intelligence (AI) may improve addiction medicine workflows and health outcomes but raises questions about data privacy and unintended harms for people who use drugs (PWUD). This qualitative study aimed to understand the perspectives of clinicians and PWUD regarding perceived benefits and concerns about clinical ...
Patrick J. A. Kelly, Elizabeth Chen, Amelia Bailey, Katie Biello, Brandon D. L. Marshall, Josiah D. Rich, Jaclyn M. W. Hughto   +6 more
wiley   +1 more source